“Study Points to Higher Risk of Breast Cancer Progression in Obese Women,” The University of Texas MD Anderson Cancer Center
A new study comparing obese mice with breast cancer and biological changes in breast cancer samples from patients appears to indicate the tie between obesity and higher risk for death. By analyzing biopsy samples from 137 ER+ breast cancer patients before they received treatment, and developing an "obese" transgenic mouse model to study how tumors begin and grow, scientists at The University of Texas MD Anderson Cancer Center were able to show evidence for how obesity may cause some wo... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 27, 2014 Category: Cancer & Oncology Source Type: news

“Aspirin Cuts Pancreatic Cancer Risk by Half, Study Finds,” Bloomberg
A recent study from Yale Cancer Center/Smilow Cancer Hospital found that Regular aspirin use cut the risk of pancreatic cancer by half, according to a finding that adds one of the most lethal malignancies to the list of diseases the inexpensive pill may help fight. Yale Cancer Center/Smilow Cancer Hospital is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 26, 2014 Category: Cancer & Oncology Source Type: news

“St. Jude Children's Research Hospital Names New CEO in Memphis,” Bloomberg Businessweek
With 28 years under his belt at St. Jude Children's Research Hospital and a global reputation for advancing the science and treatment of children with cancer, Dr. James R. Downing has a clear vision for where he wants to lead the Memphis institution as its new chief executive officer. St. Jude Children's Research Hospital/The University of Tennessee Health Science Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 25, 2014 Category: Cancer & Oncology Source Type: news

“Mayo Clinic Researchers Say Gene in Brain Linked to Kidney Cancer,” Mayo Clinic Cancer Center
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting. In this video, John A. Copland, PhD, molecular biologist and this study's senior investigator, discusses the findings of a recent study, which was published in Cancer Research. Mayo Clinic Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 24, 2014 Category: Cancer & Oncology Source Type: news

“Study Sheds Light on Racial Disparity in Colon Cancer,” University of Michigan Comprehensive Cancer Center
African-Americans with colon cancer are half as likely as Caucasian patients to have a type of colon cancer that is linked to better outcomes. The finding may provide insight into why African-Americans are more likely to die of colon cancer than Caucasians with the same stage of disease. University of Michigan Comprehensive Cancer Center is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 24, 2014 Category: Cancer & Oncology Source Type: news

"BPA Stimulates Growth of Breast Cancer Cells, Diminishes Effect of Treatment," Duke Cancer Institute
Bisphenol A (BPA), a chemical commonly used in plastics, appears to increase the proliferation of breast cancer cells, according to Duke Medicine researchers presenting at an annual meeting of endocrine scientists. Duke Cancer Institute is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 23, 2014 Category: Cancer & Oncology Source Type: news

NCCN Offers Free Patient Assistance Resource App
NCCN has launched its Reimbursement Resource App, which offers patients, providers, case managers, and payers access to payment assistance and reimbursement programs for multiple cancer types; the app is available free of charge for Apple and Android mobile devices. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) announces the availability of the NCCN Reimbursement Resource App, a free resource through which patients with cancer, providers, case managers, and paye... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 20, 2014 Category: Cancer & Oncology Source Type: news

Six Organizations Receive Grants from NCCN and Pfizer for Health Care Quality Improvement Programs in Rare Cancers
The NCCN Oncology Research Program (ORP) and Pfizer Independent Grants for Learning & Change have awarded six independent grants to implement quality improvement and health care professional education in renal cell carcinoma and hematologic malignancies. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP), in collaboration with Pfizer Independent Grants for Learning & Change (IGLC), recently awarded six independent grants to hea... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 11, 2014 Category: Cancer & Oncology Source Type: news

"Radiation for Prostate Cancer Linked to Secondary Cancers, Study Finds," University of Michigan Comprehensive Cancer Center
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan Comprehensive Cancer Center-one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 30, 2014 Category: Cancer & Oncology Source Type: news

"Study Affirms Value of Epigenetic Test for Markers of Prostate Cancer," The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
This study included researchers from The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins-one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 29, 2014 Category: Cancer & Oncology Source Type: news

"Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating," Moffitt Cancer Center
Two of North America's leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center -James Cancer Hospital and Solove Research Institute, announced Wednesday what is likely the largest collaboration of its kind to accelerate discoveries in cancer research. Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute are two of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 28, 2014 Category: Cancer & Oncology Source Type: news

"Intensity Modulated Proton Therapy Shows Benefit for Head and Neck Cancer," The University of Texas MD Anderson Cancer Center
In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment. Side effects typical of standard radiation were also reduced in some cases. These preliminary results suggest that proton therapy may be an effective and less toxic treatment option for patients with head and neck cancer. The Uni... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 27, 2014 Category: Cancer & Oncology Source Type: news

“Poorer Health of Surgery Patients on Medicaid May Alter Law’s Bottom Line,”
Surgery patients covered by Medicaid arrive at the hospital in worse health, experience more complications, stay longer, and cost more than patients with private insurance, a new study has found. The study, by researchers at the University of Michigan, may offer a preview of what to expect as millions of uninsured people qualify for Medicaid under the Affordable Care Act. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 22, 2014 Category: Cancer & Oncology Source Type: news

“Massive Dose of Measles Vaccine Clears Woman's Cancer,” USAToday.com
Mayo Clinic Cancer Center researchers announced a landmark study where a massive dose of the measles vaccine, enough to inoculate 10 million people, wiped out a Minnesota woman's incurable blood cancer. The Mayo Clinic Cancer Center-one of the 25 NCCN Member Institutions—conducted the clinical trial last year using virotherapy. The method discovered the measles virus wiped out multiple myeloma cancer calls. Researchers engineered the measles virus (MV-NIS) in a single intravenous dose, making i... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 15, 2014 Category: Cancer & Oncology Source Type: news

“A Study on Prostate Cancer Relapses Suggests that Hormone Therapy Can Wait,”
This article features commentary from physicians at Dana-Farber/Brigham and Women’s Cancer Center and Moffitt Cancer Center-two of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 14, 2014 Category: Cancer & Oncology Source Type: news